Effectiveness of immunochromatography method in lee for Helicobacter Pylori diagnostic in patients with dyspepsia

Eficacia del método de inmunocromatografía en heces para el diagnóstico de Helicobacter Pylori en pacientes con dispepsia: evaluación preliminar

Main Article Content

Martín Alonso Bayona Rojas
Andrés Julián Gutiérrez Escobar
Jeysson Fabián Sánchez Suárez
Gina Marcela Mora Camberos
Luisa Fernanda Salamanca-Muñoz
Abstract

Helicobacter pylori infection is considered one of the most important emerging diseases of this century, which is closely related with gastroduodenal tract diseases and as a predisposing factor for gastric carcinoma. For diagnosis purpose, it have been used invasive and noninvasive tests, among the latter the fecal immunochromatography, which qualitatively detect pathogen’s antigens. The aim of this study was to determine the effectiveness of this method for diagnosis of infection with H. pylori in dyspeptic patients from a hospital in Cundinamarca. Methods: We conducted a preliminary study to evaluate a diagnostic test, for which we used patients with dyspepsia history and gastric biopsy report in their medical record. Stool samples were evaluated and through the rapid test SD Bio Line H. pylori Ag™, we determined the presence of fecal H. pylori antigens. We evaluated a total of 33 patients: 48.4% men and 51.5% women, the sensitivity was 30% and specificity of 84.62%. The positive predictive value calculated was 75% and the negative predictive value was 44%. The specificity calculated for the test is comparable to that found in the literature; however, due to the reliability index’s interval showed, it would take more evidence to increase the reliability of the results shown here.

Keywords

Downloads

Download data is not yet available.

Article Details

Author Biographies (SEE)

Martín Alonso Bayona Rojas, Universidad de Ciencias Aplicadas y Ambientales

Magister en Microbiología.

Andrés Julián Gutiérrez Escobar, Universidad de Ciencias Aplicadas y Ambientales

Magister en Ciencias Básicas Médicas.

Jeysson Fabián Sánchez Suárez, Universidad de Ciencias Aplicadas y Ambientales

Magister en Bioquímica.

Gina Marcela Mora Camberos, Universidad de Ciencias Aplicadas y Ambientales

Médico.

Luisa Fernanda Salamanca-Muñoz, Universidad de Ciencias Aplicadas y Ambientales, Bogotá.

Médico.
References

Sutton, P.; Chionh, Y. Why can’t we make an effective vaccine against Helicobacter pylori?ExpertRev. Vaccines.2013; 12:433-441.

Sierra F. Helicobacter pylori – Estado actual. Revista Colombiana de Cirugía, 2002 (17): 3.

Piazuelo, M. B. y Correa, P. (2013). Gastric cancer: Overview. Colombia Médica 44(3)

World Gastroenterology Organisation Global Guideline. Helicobacter pylori in Developing Countries. Journal of Digestive Diseases 2011; 12; 319-326.

Jaramillo, Y.; Nares, J.; Martinez, V.; Velasco, V.; Márquez, F.; Manríquez, L. Chronic Gastritis Associated with Helicobacter pylori in Mexican Children: Histopathological Patterns. Pediatric and Developmental Pathology 2011; 14(2): 93-98.

Alvarado, J.; Hanl ,A.;, Rodríguez, A.; Archila, P.; Beltrán, O. Guía de práctica clínica basada en la evidencia de enfermedad ácido péptica. Asociación Colombiana de Facultades de Medicina. Colombia: Ascofame. 2005

Mohammadi M, Hashani SS, Garoosi Y, Talebkhan T, Jahangiti S. In vivo measurement of Helicobacter pylori. Meth Mol Biol 2012; 921: 239-49.

Tonkic, A.; Tonkic, M.; Lehours, P.; Mefraud, F. Epidemiology and

diagnosis of Helicobacter pylori infection. Helicobacter 2012; 17 (Suppl. 1): 1-8.

Malfertheiner, P.; Megraud, F.; O’Morain, C., et al. Management of Helicobacter pylori infection; The Maastrich IV/ Florence Consensus Report. Gut 2012; 61:646-664.

OJS System - Metabiblioteca |